Find Academic Supervisors

Tyler BoldView profile

Associate Professor

• Infectious Diseases
• Immunology
• Microbiology
• +3 more

Tyler Bold, MD, PhD serves as Associate Professor in the Division of Infectious Diseases and International Medicine within the Department of Medicine at the University of Minnesota Medical School. He concurrently holds faculty appointments in the Microbiology, Immunology and Cancer Biology (MICaB) Ph.D. Graduate Program and the Department of Medicine, establishing a multidisciplinary research presence spanning infectious disease pathogenesis, immunology, and host-pathogen interactions. His research program integrates clinical infectious disease expertise with fundamental immunological investigation, focusing on tuberculosis host-directed immunotherapy, SARS-CoV-2 pathogenesis mechanisms, and macrophage biology in atherosclerosis. Key interests include T cell costimulation in granulomatous diseases, viral-microbiome interactions during respiratory infections, and diagnostic innovations for resource-limited settings. His work bridges basic science discovery with translational clinical applications, particularly in immunocompromised populations and complex infectious syndromes. Analysis of his 15 most recent publications reveals dominant research trajectories in tuberculosis immunology (40% of articles), SARS-CoV-2 pathogenesis and therapeutics (35%), and atherosclerosis immunometabolism (15%), with emerging work on fungal infections in hematologic malignancies. The publications demonstrate consistent use of advanced techniques including single-cell resolution analysis, structural biology, and randomized clinical trials, reflecting both mechanistic depth and clinical relevance across infectious disease subspecialties.

• Surgical Oncology
• Breast Cancer
• Geriatric Oncology
• +12 more

Professor Lynda Wyld is a leading academic and clinician in surgical oncology at the University of Sheffield, affiliated with the School of Medicine and Population Health. She serves as Professor of Surgical Oncology and is an Honorary Consultant Breast Surgeon at the Jasmine Breast Centre, Doncaster. Her extensive clinical and research work focuses on improving outcomes for older women with breast cancer. Lynda Wyld earned her medical degree (MBChB) and PhD from the University of Sheffield in 1990. She completed basic surgical training in Leeds and higher surgical training across Sheffield, Nottingham, and Manchester. She was appointed Consultant and Senior Lecturer at the University of Sheffield in 2002. Her research interests center on surgical oncology, particularly breast cancer in older women, treatment decision-making, quality of life, and de-escalation of therapy. She leads the multicentre 'Age Gap' trial, which investigates optimal care pathways and decision support tools for older women with breast cancer. Her work also spans psychosocial outcomes in familial breast cancer, epigenetic modifiers of BRCA, and axillary surgery trends. Her recent publications (2023–2025) reflect a strong focus on geriatric oncology, patient-reported outcomes, and surgical decision-making. Key themes include frailty assessment, long-term outcomes of breast reconstruction, patient satisfaction with mastectomy without reconstruction, and global trends in axillary surgery de-escalation. Her research combines clinical trials, cohort studies, and qualitative methods. Chief Investigator, Age Gap Trial Collaborator with University of Cardiff, SCHARR, and Sheffield Hallam University Active contributor to European guidelines in breast cancer surgery Professor Wyld has supervised and collaborated with numerous researchers and clinicians, including J. Morgan, M. Reed, K. Collins, and others. She has no listed scientific awards in the provided text. She leads a multidisciplinary research group focused on improving cancer care for older and vulnerable populations.

• Epidemiology
• HIV
• Sexually Transmitted Infections
• +4 more

Lei Zhang is a Professor (Research) and Head of the Artificial Intelligence and Modelling in Epidemiology Program at the School of Translational Medicine, Monash University, Australia. He holds adjunct roles at institutions like Tsinghua University and is a consultant to the WHO Western Pacific Region. His expertise spans HIV/STI epidemiology, mathematical modelling, and AI-driven healthcare solutions. Education: Bachelor of Advanced Science in Mathematics (University of Sydney, 2001) Master of Science in Applied Mathematics (University of Sydney, 2003) PhD in Medicine (UNSW, 2006) Master of Public Health (Hamburg University of Applied Sciences, 2009) Research Interests: Prof. Zhang focuses on cross-disciplinary research in HIV/STI epidemiology, AI applications for disease modeling and diagnostics, health economics, and global health policy. His work integrates mathematical models with clinical data to optimize interventions and inform policy. Key Projects: HOPE: Optimizing HIV Pre-Exposure Prophylaxis (PrEP) in East Asia WHO Collaborations: Supporting global STI programs and policy development China-Australia Joint Research Center for Infectious Diseases Awards: 2021 ASRHA Innovation Award for HIV/STI research contributions Advising & Grants: Supervised 21 students (6 PhD, 15 MSc) and currently co-supervises 24 students (11 PhD, 13 MSc). Leader of 5+ major research grants, including NHMRC-funded projects on STI control and diabetes research. Labs/Teams: Leads the AI & Modelling in Epidemiology Program and collaborates with global networks like UNAIDS, the World Bank, and ministries of health across the Western Pacific region.

• Child Language Disorders
• Developmental Language Disorder
• Autism Spectrum Disorder
• +5 more

Nicole Magaldi is a Professor in the Department of Communication Sciences and Disorders at Long Island University, School of Health Professions. With over 20 years of clinical experience in hospitals, early intervention, schools, and private practice, she brings a strong applied perspective to her academic work. Her expertise centers on child language disorders, particularly Developmental Language Disorder and Autism Spectrum Disorder. Educational Background: B.S., Cortland University M.A., Kean University Ph.D., New York University Dr. Magaldi's research focuses on evidence-based practice in child language disorders, clinical education methods, and the impact of reproductive factors on neurodevelopmental outcomes. She has published extensively on terminology navigation, pedagogical tools like problem-based learning, and early identification of autism. Her work bridges clinical practice and academic training, emphasizing practical solutions for clinicians and educators. The recent publications highlight a growing interest in integrating educational strategies with clinical rigor, particularly in training future speech-language pathologists. Her research also explores environmental and reproductive risk factors associated with Autism Spectrum Disorder, contributing to broader public health understanding. Scientific Awards: Dissertation of the Year, New York University Dr. Magaldi is actively involved in professional development through her membership in the American Speech-Language-Hearing Association (ASHA) and service on the Professional Development Committee for ASHA’s Special Interest Group 1 (SIG 1). While specific grant details are not listed, her sustained research output suggests ongoing scholarly and possibly funded activity. She mentors graduate students through research collaboration and clinical supervision, though no named advisees are listed. She is affiliated with the Department of Communication Sciences and Disorders, which operates under the School of Health Professions at LIU. Her work contributes to both clinical innovation and academic advancement in speech-language pathology.

• Physical Activity
• Fall Prevention
• Healthy Ageing
• +3 more

Dr Juliana Souza de Oliveira is a Postdoctoral Research Fellow at the Institute for Musculoskeletal Health , a partnership between the University of Sydney and Sydney Local Health District. She holds an Adjunct Senior Lecturer position at the Sydney School of Public Health , Faculty of Medicine and Health. Her research focuses on physical activity interventions to promote healthy ageing and prevent falls in older populations, particularly through yoga and digital health (teleyoga) programs. Primary Affiliation: University of Sydney Sub-Affiliation: Sydney School of Public Health Research Partners: Sydney Local Health District, WHO, NHMRC Research Themes include fall prevention , healthy ageing , digital health interventions , and physical activity promotion . Her work spans clinical trials, systematic reviews, and meta-analyses, with a focus on community-dwelling older adults. Recent Publications (2024-2015) address topics such as fall risk factors , yoga-based interventions , sarcopenia in chronic kidney disease , cost-effectiveness of exercise programs , and teleyoga adoption during pandemics . These studies employ methodologies like randomised controlled trials , systematic reviews , and realist evaluations . Scientific Awards and Grants include funding from the Physiotherapy Research Foundation , NHMRC , and AHRA Women's Health Research Network . Her work also intersects with organisations like the Australian Association of Gerontology and International Society of Behavioral Nutrition & Physical Activity (ISBNPA) . Advisory and Collaborative Efforts extend to Charlotte KILMARTIN and Ima STRKLJEVIC , with whom she explores inpatient fall reduction and physiotherapist-led activity promotion . She collaborates extensively on NHMRC-funded trials and WHO guideline development .

• Sarcoma Immunotherapy
• Osseointegration
• Limb Salvage
• +4 more

Dr. Rosanna Wustrack is a Professor of Orthopaedic Surgery at the University of California, San Francisco (UCSF) School of Medicine, where she serves as the Chief of Orthopedic Oncology. She specializes in the surgical diagnosis and treatment of musculoskeletal tumors and fragility fractures, with a focus on limb salvage procedures and complex reconstructive surgery. Her educational background includes a BA in Biology from Yale University (1999), an MD from Washington University School of Medicine in St. Louis (2006), residency in Orthopedic Surgery at UCSF (2012), fellowship in Musculoskeletal Oncology at Memorial Sloan Kettering Cancer Center (2013), and Advanced Training in Clinical Research from UCSF (2014). She also completed Diversity, Equity, and Inclusion Champion Training at UCSF in 2018. Dr. Wustrack's research focuses on immunotherapy for sarcomas, functional outcomes in cancer patients, osseointegration, and optimizing treatment for metastatic disease. Her work also extends to global health initiatives and addressing osteoporosis in cancer survivors. She has made significant contributions to understanding tumor immunology, developing innovative reconstructive techniques, and improving outcomes for patients with musculoskeletal tumors. Her extensive publication record demonstrates expertise across sarcoma biology, orthopedic oncology, and innovative reconstructive techniques. The articles reveal a strong emphasis on translational research, with particular focus on sarcoma immunology, osseointegration technology, and outcomes research in musculoskeletal oncology. Her work bridges basic science with clinical applications, particularly in developing novel approaches to sarcoma treatment and improving prosthetic integration. UCSF Department of Orthopedic Surgery 2012 Mauer Chief Resident of the Year UCSF Department of Orthopedic Surgery 2016 James O. Johnston Resident Teaching Award UCSF Academy of Medical Educators 2018 Excellence in Teaching Award Musculoskeletal Research Society 2019-2020 Mentored Research Award UCSF Department of Orthopedic Surgery 2020 Compassionate Physician Award UCSF Health 2020 Exceptional Physician Award Dr. Wustrack serves as Principal Investigator on the Musculoskeletal Tumor Society grant "Identifying and enhancing the host immune response in adult soft tissue sarcoma" and as Co-Investigator on Department of Defense-funded research on osseointegration and neural-controlled prosthetics. Her work with the UCSF Sarcoma Center and Osseointegration Program (iCORES) demonstrates her commitment to multidisciplinary approaches to complex oncologic problems. She is actively involved in global health initiatives through the Institute for Global Health Sciences, focusing on improving surgical care access worldwide.

• posttraumatic stress disorder
• prolonged grief disorder
• global mental health
• +5 more

Scientia Professor Richard Bryant is a leading researcher in trauma psychology at the University of New South Wales, where he serves in the School of Psychology. With over three decades of research experience, he has established himself as a world authority on posttraumatic stress disorder (PTSD), prolonged grief disorder, and trauma-related mental health conditions. Professor Bryant received his B.A. (Hons.) from the University of Sydney in 1983, followed by his M.Clin. Psych. and Ph.D. from Macquarie University in 1986 and 1989 respectively. He was awarded a D.Sc. from UNSW in 2016, recognizing his substantial contributions to the field. His clinical training and academic background have positioned him at the forefront of trauma research and treatment development. Dr. Bryant's research primarily focuses on posttraumatic stress disorder, prolonged grief disorder, global mental health initiatives, cognitive behavior therapy applications, and clinical trials methodology. His work spans diverse populations including trauma survivors, refugees, first responders, and individuals affected by disasters. He has pioneered early intervention approaches following traumatic events and developed innovative treatments for persistent trauma reactions across various cultural contexts. An analysis of his recent publications reveals a strong emphasis on global mental health applications, particularly in conflict zones and with displaced populations. His research increasingly incorporates digital health solutions, examines cultural variations in trauma response, and investigates novel treatment approaches including memory specificity training and integration of technology in therapy delivery. His work consistently bridges clinical practice with research evidence to improve mental health outcomes worldwide. Professor Bryant maintains an active research program with numerous ongoing clinical trials and international collaborations. His work has significantly influenced clinical guidelines for trauma treatment globally, particularly through his contributions to World Health Organization interventions and evidence-based practice recommendations. Based at the University of New South Wales in Sydney, Professor Bryant continues to mentor emerging researchers while maintaining a robust publication record that demonstrates both depth and breadth across trauma psychology domains. His Mathews Building office serves as the hub for a productive research team investigating critical questions in trauma response and recovery.

• Abdominal Imaging
• Body Imaging
• LI-RADS (Liver Imaging Reporting and Data System)
• +4 more

Tasneem Kassam Lalani serves as an Associate Professor of Radiology at UMass Chan Medical School, specifically within the T.H. Chan School of Medicine. She specializes in Abdominal Imaging and maintains an active clinical and academic presence at the institution. Education Background: BS in Zoology from University of British Columbia, Vancouver, BC, Canada MS in Physiology/Respiratory Biology from Harvard University, Cambridge, MA, United States MD from University of Alberta, Edmonton, AB, Canada Internship (Rotating) at Greater Victoria Hospitals, University of British Columbia, Victoria, BC, Canada Residency in Radiology at M.D. Anderson Cancer Center, University of Texas, Houston, TX Fellowship in Body Imaging at University of Toronto, Toronto, ON, Canada Mini Fellowship in Chest Radiology and HRCT at University of British Columbia, Vancouver, BC, Canada Dr. Lalani's research focuses primarily on abdominal imaging, with special expertise in liver imaging using the Liver Imaging Reporting and Data System (LI-RADS). Her work spans gastrointestinal radiology, oncologic imaging, and vascular imaging. She has made significant contributions to the American College of Radiology (ACR) Appropriateness Criteria, developing patient-friendly summaries for various clinical scenarios. Her research demonstrates a strong commitment to improving diagnostic accuracy, standardizing imaging protocols, and enhancing patient education in radiology practice. Analysis of her publication history reveals consistent contributions to abdominal imaging literature, with recent emphasis on implementation strategies for LI-RADS, technical optimization of CT/MRI for liver imaging, and development of patient-friendly imaging guidelines. Her work shows strong collaboration with national radiology experts and has been incorporated into clinical practice guidelines. Dr. Lalani serves as a key contributor to the ACR Appropriateness Criteria panels, particularly in areas related to abdominal imaging, gastrointestinal disorders, and liver disease. Her expertise is recognized through her numerous publications in high-impact radiology journals and her role in shaping evidence-based imaging guidelines. She maintains active collaborations with colleagues across multiple institutions, particularly in the development and implementation of standardized imaging protocols. Her work bridges clinical practice with academic research, focusing on practical applications that improve patient care and diagnostic accuracy in radiology.

Brin GrenyerView profile

Professor

• Clinical psychology
• Personality disorders
• Borderline Personality Disorder
• +7 more

Brin Grenyer OAM is Senior Professor of Psychology at the University of Wollongong and Director of the Project Air Strategy for Personality Disorders, in partnership with NSW Health. He is an internationally recognised leader in the science and treatment of personality disorders and serves as President-Elect of the International Society for the Study of Personality Disorders (ISSPD) with a term spanning President-Elect (2022-23), President (2024-25), and Past President (2026-2027). Professor Grenyer maintains active clinical practice through the Northfields Psychology Clinic and consults widely on patient care issues across NSW, Australia, and internationally. Professor Grenyer's research program focuses on the psychotherapy treatment of chronic and complex psychological problems, with particular emphasis on personality disorders (especially Borderline Personality Disorder), self-harm, suicidal ideation, chronic depression, aggression and violence, early attachment relationships, and substance dependence. His methodological approach integrates quantitative clinical measures, biomedical assessments, psychotherapy process research, qualitative lived experience narratives, and longitudinal studies to develop comprehensive understanding of complex mental health conditions. Analysis of Professor Grenyer's recent publications reveals a sophisticated evolution in his research focus, with increasing attention to dimensional assessment frameworks like ICD-11, gender differences in personality pathology, digital interventions (particularly the Air Therapy program), telehealth delivery of psychotherapy, and implementation science approaches to integrate evidence-based treatments into healthcare systems. His work demonstrates a consistent commitment to bridging research evidence with clinical practice while incorporating lived experience perspectives. Professor Grenyer's scientific contributions have been recognized through significant awards: Medal of the Order of Australia (OAM) for service to psychology (2021) College of Clinical Psychologists Ian M Campbell Memorial Prize (2020) World top 1% (top 0.21%) of experts in Borderline Personality Disorder (2011-2021) Professor Grenyer has supervised numerous doctoral and master's students across a wide spectrum of topics related to personality disorders, self-harm, and psychotherapy processes. His research program has secured over 50 grants totaling more than $18 million in funding from diverse sources including NHMRC, university strategic funds, and health organizations. Major projects include the Air Therapy initiative, Project Air Strategy for Personality Disorders, and studies on lived experience perspectives in mental health services. Professor Grenyer directs the Project Air Strategy for Personality Disorders and maintains clinical involvement through the Northfields Psychology Clinic. His work uniquely integrates academic research, clinical practice, professional leadership (including his role as Foundation Chair of the Psychology Board of Australia from 2009-2018), and healthcare system implementation to advance the field of personality disorders treatment.

Jeremy M G TaylorView profile

Professor

• Biostatistics
• Survival Analysis
• Longitudinal Data Analysis
• +5 more

Jeremy M G Taylor is the Pharmacia Research Professor of Biostatistics and holds professorships in the Department of Radiation Oncology in the School of Medicine and the Department of Computational Medicine and Bioinformatics at the University of Michigan. He serves as the Associate Director for Biostatistics at the Comprehensive Cancer Center and directs both the University of Michigan Cancer Center Biostatistics Unit and the Cancer/Biostatistics training program. His educational background includes: B.A. in Honours Mathematics from Cambridge University (1978) Dip. Stat. in Statistics from Cambridge University (1979) PhD in Statistics from University of California, Berkeley (1983) Professor Taylor's research focuses on the theory and application of statistics to biomedical problems, with an emphasis on data-driven, robust, and flexible statistical methods that incorporate scientific knowledge from specific research domains. His theoretical interests span Box-Cox power transformations, robust methods, causal inference, nonparametrics, and smoothing techniques. His applied work centers on cancer and AIDS research, particularly in radiation oncology, where he has developed methods involving mixture models, stochastic processes, multistate models, and multiple imputation. His extensive publication record demonstrates a continued focus on survival analysis, longitudinal data modeling, biomarker evaluation, and clinical trial design. Recent work explores time-varying effects, joint modeling approaches, multiple imputation techniques, and the integration of external information into statistical models, with applications across various cancer types including prostate, head and neck, and liver cancers. Awarded the Mortimer Spiegelman Award from the American Public Health Association, the Michael Fry Award from the Radiation Research Society, and the Jerome Sacks Award from the National Institute of Statistical Sciences, Professor Taylor has established himself as a leading biostatistician in cancer research methodology. With over 35 years of academic experience (UCLA 1983-1998, University of Michigan 1998-present), Professor Taylor has maintained an active research program while mentoring numerous students and collaborating extensively with clinical researchers. His work bridges sophisticated statistical methodology with practical applications in cancer treatment and outcomes research. As director of the Cancer Center Biostatistics Unit and the Cancer/Biostatistics training program, he leads a significant research team focused on advancing statistical methods for cancer research and training the next generation of biostatisticians.

Christina A. RobertoView profile

Professor

• Nutrition and Health Policy
• Public Health
• Behavioral Economics
• +2 more

Christina A. Roberto, PhD , Mitchell J. Blutt and Margo Krody Blutt Presidential Professor of Health Policy at the Perelman School of Medicine, University of Pennsylvania. She directs the Psychology of Eating and Consumer Health (PEACH) Lab and serves as Associate Director of the Center for Health Incentives and Behavioral Economics at Penn. Current National Academy of Medicine Emerging Leader Fellow Robert Wood Johnson Foundation Health and Society Scholar Completed clinical internship at Yale School of Medicine Research Focus: The PEACH Lab addresses food policy and behavioral economics to combat nutrition-related chronic diseases, emphasizing health equity. Her work bridges academic research with real-world applications for policymakers, community organizations, and institutions. Nutrition policy development Behavioral economics in health Food environment interventions Health equity promotion Chronic disease prevention Scientific Recognition: Robert Wood Johnson Foundation Health and Society Scholar National Academy of Medicine Emerging Leader Fellow Email: croberto@pennmedicine.upenn.edu

Daphna HarelView profile

Associate Professor

• Survey Methodology
• Measurement Theory
• LGBTQIA+ Data Analysis
• +6 more

Daphna Harel (she/her) serves as Associate Professor of Applied Statistics and Director of the A3SR MS Program within the Department of Applied Statistics, Social Science, and Humanities at New York University's Steinhardt School of Culture, Education, and Human Development. She holds leadership roles including PI of the NYU QUEER data lab and membership on the steering committee for the DEPRESSD project. Education: PhD in Mathematics and Statistics from McGill University Harel's research focuses on measurement challenges in survey methodology, particularly for self-reported questionnaires in health and social sciences. Her work bridges theoretical statistics with practical applications in LGBTQIA+ data collection, differential item functioning, and patient-reported outcomes. She develops methodological frameworks for polytomous Item Response Theory and creates guidelines for statistical analysis of complex survey data. Her recent work emphasizes improving statistical practice for LGBTQIA+ populations and advancing queer data collection methods. Her publication portfolio demonstrates consistent focus on measurement validity across diverse health contexts, with recent work expanding into LGBTQIA+ data science. Her research shows increasing emphasis on methodological innovations for gender and sexuality measurement, with multiple publications presented at major conferences including AAPOR 2024 and LGBTQ+ Health Conference 2024. Research Leadership: PI of NYU QUEER data lab (founded Fall 2022) Steering committee member for DEPRESSD project Collaborator with Scleroderma Patient-centered Intervention Network Recipient of NIH R21 funding and NYU intramural grants Harel mentors a diverse team of graduate students through the Applied Statistics for Social Science Research program, focusing on inclusive research methods for marginalized populations. Her grant portfolio includes investigations into transgender voice training, LGBTQIA+ survey methodology, and healthcare access for gender-affirming services. Laboratory Leadership: As founder and PI of the NYU QUEER data lab, Harel leads research projects examining survey question design for gender/sexuality measurement, content moderation effects on hate speech, and accessibility of transgender voice training. The lab operates through collaboration between NYU Steinhardt and the NYU BITS lab, with research assistants drawn from the Applied Statistics MS program.

Menno DouwesView profile

Assistant Clinical Professor

• Pediatric Cardiology
• Congenital Heart Diseases
• Pulmonary Hypertension
• +3 more

Menno Douwes is a pediatric cardiologist and researcher at the University of Groningen's Faculty of Medical Sciences, specializing in Vascular Medicine. He holds both MD and PhD credentials, with his doctoral work focused on Pediatric Pulmonary Arterial Hypertension completed cum laude in 2017. His research interests center on advancing the field of congenital heart diseases, with special focus on pulmonary vascular and ventricular adaptation to abnormal loading conditions. His work contributes to UN Sustainable Development Goals related to health and well-being. Dr. Douwes has published extensively in the field of pediatric pulmonary hypertension, with research focusing on risk stratification, therapeutic approaches including prostanoids and pirfenidone, and innovative methods for assessing disease severity through physical activity monitoring. His recent work shows a strong emphasis on translating experimental findings into clinical practice. Dekkerbeurs research grant from Hartstichting (2023) Half-million euro research grant for pediatric cardiovascular research (2023) Dr. Douwes actively contributes to the academic community through organizing conferences including the 5th European Conference on Neonatal and Paediatric Pulmonary Vascular Disease (2023). His research has received significant attention with multiple publications garnering substantial citations and media coverage. His educational background includes a Medical Degree from the University of Groningen (2009), PhD in Pediatric Pulmonary Arterial Hypertension (2017), Pediatrician certification (2019), and Paediatric Cardiologist specialization (2022), demonstrating a dedicated career path in pediatric cardiovascular medicine.

Hongzhe LiView profile

Professor

• bioinformatics
• biostatistics
• computational biology
• +3 more

Hongzhe Li is a Professor of Biostatistics and Director of the Laboratory of Statistical Genetics and Genomics. His research spans methodological and collaborative work in bioinformatics, biostatistics, computational biology, statistical genetics, genomics, and metagenomics, with applications to complex human diseases. His primary research focuses on developing statistical methodologies for multi-omics data integration, particularly in microbiome-host interactions. Key areas include robust high-dimensional modeling, transfer learning, mediation analysis with complex mediators, and phylogenetic methods. His work addresses critical challenges in analyzing compositional data, longitudinal microbiome dynamics, and multi-tissue genetic studies, with significant applications in inflammatory bowel disease, kidney disease progression, and rare disorders like Castleman disease. Recent publications (2023-2025) demonstrate a cohesive trajectory in advancing statistical frameworks for microbiome and multi-omics research. Dominant themes include transfer learning for high-dimensional models, mediation analysis with distributional mediators, and robust covariance estimation. These methods are consistently applied to translational problems in gastroenterology, nephrology, and rare hematologic diseases, emphasizing clinical utility through prospective cohort studies and multi-omics integration. Scientific Awards: No awards mentioned in provided text. Advising and Grants: Student advising details and grant information absent from source material. Research appears driven by methodological innovation with strong clinical collaborations, particularly in IBD and kidney disease consortia. Laboratory: Leads the Laboratory of Statistical Genetics and Genomics, which develops computational frameworks for genetic and microbiome data analysis. The lab specializes in creating open-source statistical tools for high-dimensional biological data, with emphasis on reproducibility and clinical translation through partnerships with medical researchers.

Viet-Huong NguyenView profile

Associate Professor

• Epilepsy
• Stroke
• Genetics
• +2 more

Dr. Viet-Huong Nguyen serves as an Associate Professor in Pharmacy Practice at Chapman University's School of Pharmacy, located at the Rinker Health Science Campus. Her expertise spans epilepsy, stroke, genetics, neuropharmacology, and epidemiology, with a focus on clinical and translational research. Her educational background includes: Bachelor of Arts in Biology and Classics with emphasis in Literature and Mythology from University of Southern California (2001) Master of Science in Cell and Neurobiology from University of Southern California (2003) Doctor of Pharmacy from University of California, San Francisco (2007) Master of Public Health in Epidemiology from University of California, Los Angeles (2014) Dr. Nguyen's research primarily focuses on epilepsy and stroke, with particular interest in the pharmacogenetics of drug response and resistance in epilepsy. She is an active member of GENESS, an international consortium dedicated to identifying genes causing genetic epilepsies including Juvenile Myoclonic Epilepsy, Childhood Absence Epilepsy, and Lafora Epilepsy to develop curative therapies. Her work bridges basic neuroscience with clinical applications, investigating molecular signaling pathways of the central nervous system and their implications for pharmacotherapy. She has contributed significantly to stroke outcomes/health services research, examining risk factor management and treatment protocols across multiple healthcare settings. Her extensive publication record demonstrates a consistent focus on neuropharmacology, with particular emphasis on epilepsy management and stroke care. The publications span clinical guidelines, pharmacogenetic research, and innovative approaches to treatment. Her work shows progression from basic pharmacokinetic studies to complex clinical applications and health services research, with increasing focus on genetic factors influencing drug response. The publications reveal a strong collaborative approach, frequently working with international research teams across multiple institutions. Her notable recognition includes: Fellowship grant from the American Foundation of Pharmaceutical Education (AFPE) to study drug transporters and pharmacogenetics in drug resistant epilepsy Dr. Nguyen has mentored and precepted over 80 students and residents from VAGLAHS, USC, UCSF, UOP, and Western University Schools of Pharmacy. She previously served as an Adjunct Assistant Professor of Pharmacy Practice at USC School of Pharmacy for 8 years, contributing to curriculum development for epilepsy and stroke education. Her clinical work has included developing the Anti-Epileptic Drug Response Phenotype Database and establishing pharmacist-managed Epilepsy and Stroke Prevention clinics with expanded scope of practice. She was instrumental in developing the PGY2 specialty pharmacy practice residency in Neurology at VA Greater Los Angeles Healthcare System (VAGLAHS), the first neurology pharmacy residency eligible for ASHP accreditation. Her clinical practice has centered around the VAGLAHS Epilepsy Center of Excellence and Stroke Program, where she implemented innovative pharmacy services that have improved patient outcomes through specialized pharmacotherapy management.